Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Eur J Cancer. 2020 May 24;134:41–51. doi: 10.1016/j.ejca.2020.04.024

Figure 1. CONSORT Diagram.

Figure 1

HCC- Hepatocellular carcinoma; SBRT- Stereotactic Body Radiotherapy; *At Princess Margaret Cancer Centre, patients who underwent planned SBRT as a bridge to transplant received SBRT to reduce the tumor burden to within transplant criteria, rather than for definitive treatment (and often all HCCs were not always targeted and SBRT doses were often reduced); hence they were excluded from this analysis. At University of Michigan, no patients were identified as eligible for transplant upfront. However, a subset of patients subsequently became eligible for transplant, and are included in this analysis.